Recently, an in vitro cell culture study with human myofibers using interferon gamma (IFN-γ)-induced muscle wasting corroborated the use of tofacitinib and baricitinib (JAK/STAT inhibitors), two commonly prescribed therapeutics for rheumatoid arthritis (RA), which fully hindered muscle atrophy [89]. Here, IFNG is linked to rheumatoid arthritis.